Earnings results expected in 22 days
Summary
J4D closed Friday higher at €20.14, an increase of 1.21% from Thursday's close, completing a monthly decrease of -3.52% or €0.73. Over the past 12 months, J4D stock lost -3.52%.
J4D pays dividends to its shareholders, with the most recent payment made on Nov 27, 2024. The next estimated payment will be in In 1 month on Feb 27, 2025 for a total of €0.205.
The last earnings report, released on Nov 07, 2024, exceeded the consensus estimates by 0.01%. On average, the company has surpassed earnings expectations by 0.03%, based on the last three reports. The next scheduled earnings report is due on Feb 06, 2025.
The stock of the company had never split.
The company's stock is traded on 6 different exchanges and in various currencies, with the primary listing on XFRA (EUR).
Want to track J4D and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
J4D Chart
FAQ
What Is the Kenvue Inc.(J4D) Stock Price Today?
The J4D stock price today is €20.14.
What Stock Exchange Does Kenvue Inc. Trade On?
Kenvue Inc. is listed and trades on the NYSE.
What Is the Stock Symbol for Kenvue Inc.?
The stock symbol for Kenvue Inc. is "J4D".
Does Kenvue Inc. Pay Dividends? What's The Current Dividend Yield?
J4D is not paying dividends to its shareholders.
What Is the Kenvue Inc. Market Cap?
As of today, Kenvue Inc. does not have a market cap available.
What is Kenvue Inc. Earnings Per Share?
The Kenvue Inc. EPS is 0.31.
What Is the Next Kenvue Inc. Earnings Date?
Kenvue Inc. will release its next earnings report on Feb 06, 2025.
Did Kenvue Inc. had any splits?
No, Kenvue Inc. has never had a stock split.
Kenvue Inc. Profile
| Household & Personal Products Industry | Consumer Defensive Sector | Mr. Thibaut Mongon CEO | XFRA Exchange | US49177J1025 ISIN |
| US Country | 22,000 Employees | 13 Nov 2024 Last Dividend | - Last Split | 4 May 2023 IPO Date |
Overview
Kenvue Inc. is a global consumer health firm that offers a wide range of healthcare products through its diverse operational segments: Self Care, Skin Health and Beauty, and Essential Health. Founded in 2022 and headquartered in Skillman, New Jersey, Kenvue Inc. delivers a comprehensive portfolio of products designed to improve the wellness and health of consumers around the world. By leveraging well-known brands across its segments, Kenvue provides solutions for everyday health concerns, from pain relief and cold prevention to skincare and baby care.
Products and Services
- Self Care: This segment encompasses products for cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and more. Notable brands include Tylenol for pain relief, Motrin for inflammation, Benadryl for allergies, Nicorette for smoking cessation, Zarbee's and ORSLTM for general wellness, Rhinocort for nasal congestion, Calpol for children's fever and pain, and Zyrtec for 24-hour allergy relief.
- Skin Health and Beauty: Dedicated to maintaining skin health and enhancing beauty, this segment offers products for face and body care, hair care, sun protection, and more. It includes Neutrogena for skincare and acne treatment, Aveeno for moisturizers with natural ingredients, Dr.Ci:Labo for innovative skin solutions, Le Petit Marseillais for shower gels and soaps with enchanting fragrances, Lubriderm for daily moisture, Rogaine for hair regrowth, and OGX for salon-inspired hair care.
- Essential Health: Focusing on essential healthcare needs, this segment provides oral care, baby care, women's health, wound care, among other products. It features Listerine for oral health, Johnson's products for baby care, Band-Aid for wound protection, Stayfree pads, o.b. tampons, and Carefree liners for feminine hygiene, as well as Desitin Diaper Rash cream to soothe and protect infants.
Contact Information
Address: 199 Grandview Road, Skillman, NJ, United States, 08558
Phone: 908-874-1200
Website: https://www.kenvue.com
2025 © Marketlog. All Rights Reserved.
